Clinical trial

Clinical Outcomes of Exenatide Versus Basal Insulin

NCT02987348

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-06-30

PhaseN/A

Study timeline

Study start (actual)2015-06-30Date precision: day

Registry last updated2017-03-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

exenatide once weeklyDRUG

exenatide twice dailyDRUG

basal insulinDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02987348 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.